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INTRODUCTION
The steps by which Type 2 diabetes melli-
tus (T2DM) causes atherosclerotic vascular dis-
ease are not clear. Emphasis is shifting from elu-
cidation of risk factors, such as insulin resistance,
to an understanding of the process occurring at
the vasculature (Playford and Watts, 1999). An
increase in the concentration of serum sialic acid
has been shown to be a possible cardiovascu-
lar risk factor in patients with non insulin depen-
dant diabetes (Crook et al, 1993). The earliest
event associated with atherosclerosis is the ac-
cumulation of low density lipoprotein cholesterol
(LDL) and fibrinogen /fibrin in the affected arte-
rial wall (Smith and Staples, 1980). It is there-
fore important to understand the mechanisms,
which govern the endothelial binding, uptake,
and transport of these macromolecules across
the vessel wall as a prerequisite to the preven-
tion of atherogenesis. The role of the luminal
endothelial plasma membrane may be particu-
larly relevant because it is the first interface be-
tween the vessel wall and circulating blood com-
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Abstract. The concentration of plasma sialic acid was estimated using the modified chemical method
and the more sensitive enzymatic method in 20 subjects with impaired glucose tolerance and 20
control subjects. The mean sialic acid concentration values of the control subjects and subjects with
impaired glucose tolerance using the enzymatic method were 1.747 ± 0.047 and 2.583 ± 0.070
mmole/l and 1.753 ± 0.067 and 2.591 ± 1.02 mmole/l for the chemical method. The intra-assay
coefficient of variation for the control subjects and for the subjects with impaired glucose tolerance
were 1.963% and 1.583%, respectively, for the enzymatic assay and 2.728% and 2.431%, respec-
tively, for the chemical assay. The inter-assay coefficient of variation for the control subjects and for
the subjects with impaired glucose tolerance were 2.686% and 2.723% for the enzymatic assay,
and 3.819% and 3.95% for the chemical assay. Since the values do not differ significantly, the
chemical assay is a cost effective method that can be used in large epidemiological studies.
ponents. The luminal surface of the endothelium
is rich in sialoglycated proteins and thus pro-
vides an anionic barrier for the receptor medi-
ated uptake of LDL. It has been shown that the
removal of sialic acid, as well as glycosaminogly-
cans, increases the internalization of LDL by 20
fold (Gorog and Pearson, 1984). Thus, desialy-
lation at the endothelium could be an early event
in the atherosclerotic process of cardiovascular
disease and in NIDDM.
Recent evidence suggests that inflamma-
tory processes play a part in the cause of ath-
erosclerotic cardiovascular disease (Ross, 1999)
and that the increase in acute phase proteins
rich in sialoglycated proteins in serum reflects
the atherosclerotic process in the endothelium
(Pickup et al, 1997). Thus, an increase in the
acute phase proteins may partly explain the el-
evation of serum sialic acid in Type 2 DM. Since
sialic acid is a marker for the early atheroscle-
rotic process and is present in most acute phase
proteins, there is a need for a specific assay,
which is cost effective, and can be employed in
large scale epidemiological studies. In our labo-
ratory, we have modified the periodate resorci-
nol method (Jourdian et al, 1971) for the mea-
surement of total sialic acid, and compared the
values to those obtained with the enzymatic as-
say (Simpson et al, 1993).
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 MATERIALS AND METHODS
Subjects
Twenty control subjects were studied along
with 20 first-degree relatives with asymptomatic
impaired glucose tolerance (IGT), who were age
matched. The control subjects with a body mass
index of < 30kg/m2 were chosen randomly from
the Klang Valley, Kuala Lumpur, through the dis-
tribution of questionnaires. Any subject with a
family history of diabetes, hypertension, or coro-
nary artery disease were excluded from the
study. First degree relatives with an impaired glu-
cose tolerence test (IGT) were chosen from dia-
betic families through the diabetic clinic, Univer-
sity of Malaya Medical Center, Kuala Lumpur. The
study was approved by the Ethics Committee of
the Medical Center. None of the subjects had
received hypolipidemic drug therapy, nor had any
renal, hepatic or thyroid disease affecting glu-
cose or lipid metabolism.
Sialic acid determination
Fasting blood was collected in bottles con-
taining disodium ethylene diamine tetraacetate
dehydrate (EDTA), and the plasma was sepa-
rated immediately by centrifugation at 3,000 rpm
for 15 minutes at 4ºC and the sialic acid was
measured using the enzymatic method or the
periodate-resorcinol method. Sialic acid was
determined by the enzymatic method as de-
scribed by Simpson et al (1993). The glycopro-
tein was hydrolysed by neuraminidase, and the
sialic acid was cleaved by the second enzyme N-
acetyl neuraminic acid adolase, which produced
pyruvate. The pyruvate was oxidized by the pyru-
vate oxidase in the presence of FAD and the hy-
drogen peroxide released was measured colori-
metrically by peroxidase in the presence of 4-
amino antipyrine and N-ethyl-N-2-hydroxyethyl-
3-toluidine, when a red product was formed. The
optical density was measured at 630 nm using a
MRX ELISA reader. The enzymatic assay was
done using the reagents supplied by the manu-
facturers (Boehringer Manheim). Reproducible
results were obtained when the plasma was fil-
tered with the Millipore filters supplied by the
manufacturer (Qiagen). Total sialic acid was de-
termined chemically as described by Jourdian
et al (1971). The plasma samples were filtered
and a sample containing not more than 0.2 µmol
of N-acetyl neuraminic acid in a total of 0.5 ml
was added to 0.1 ml of 0.04 M periodic solu-
tion. The solutions were thoroughly mixed and
allowed to stand in an ice bath for 20 minutes.
After the addition of the resorcinol reagent, the
solutions were mixed and allowed to stand in
an ice bath for 5 minutes. This mixture was
heated at 100ºC, for 15 minutes and cooled un-
der tap water. Tert–butyl alcohol was added to
the mixture and mixed vigourously to give a single
phase. The tubes were then transferred to a 37ºC
water bath for 3 minutes to stabilize the color
and cooled to room temperature. One hundred
thirty microliters of the mixture was transferred
to microtiter plates and the absorbance was de-
termined at 630nm (λ max =626nm) using a
MRX ELISA reader. The above assay was adapted
so that the reaction could be carried out on
microtiter plates. Standard curves for both the
enzymatic and resorcinol-periodate method rang-
ing from 0 to 1.0 µmole were plotted using N-
acetyl neuraminic acid obtained from the manu-
facturer (Sigma). Pyruvate, in the range of 0.3-
0.7 mg/100 ml, did not interfere with the chemi-
cal assay.
Statistical analysis
Data were expressed as mean ± standard
deviation. The coefficient of variation was cal-
culated using SPSS and Microsoft EXCEL pack-
ages.
RESULTS
From Table 1, the mean sialic acid concen-
tration for the control subjects using enzymatic
assay method was 1.747±0.047 mmole/l and for
the chemical method it was 1.753±0.067 mmole/
l. For the enzymatic assay, the intra- and inter-
assay coefficients of variation were 1.96% and
2.69%, respectively. The corresponding values
for the chemical assay were 2.73% and 3.82 %,
respectively. The mean sialic acid concentration
for the subjects with IGT using enzymatic assay
method was 2.583±0.070 mmole/l and for the
chemical method it was 2.591±1.02 mmole/l. For
the enzymatic assay, the intra- and inter-assay
coefficients of variation were 1.58% and 2.72%,
respectively. The corresponding values for the
chemical assay were 2.43% and 3.95 %, respec-
tively.
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From Table 2, the 95% confidence intervals
for the mean sialic acid concentrations for con-
trol subjects using the enzymatic and chemical
methods were 1.726, 1.768 and 1.724, 1.782,
respectively. For subjects with IGT, the 95% con-
fidence interval for the mean sialic acid concen-
tration using the enzymatic and chemical meth-
ods were 2.552, 2.614 and 2.144, 3.038, re-
spectively.
DISCUSSION
The inter- and intra-assay coefficients of
variation for the chemical method is quite simi-
lar to that of enzymatic method. Thus, the ac-
curacy of estimation is about the same for the
two methods. For both control subjects and sub-
jects with IGT, the 95% confidence intervals for
mean sialic acid concentrations using chemical
and enzymatic methods overlap each other. Fur-
thermore, the point estimates for the chemical
methods fall within the respective interval esti-
mates for enzymatic methods. Thus, the chemi-
cal method is not significantly different from the
enzymatic method in estimating the mean sialic
acid concentration. Therefore, the chemical as-
say ia a cost-effective method and can be used
in large epidemiological studies
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Table 1
Comparison of enzymatic and chemical assays.
Measure Enzymatic Chemical Enzymatic Chemical
IGT=Impaired glucose tolerance; CV=Coefficient of variation
1.747 ± 0.047
1.96%
2.69%
1.753 ± 0.067
2.73%
3.82%
2.583 ± 0.070
1.58%
2.72%
2.591 ± 1.02
2.43 %
3.95%
Mean ± SD (mmole/l)
Intra-assay CV
Inter-assay CV
Control subjects                                    Subjects with IGT
Table 2
95% Confidence Intervals for mean concentrations.
Enzymatic Chemical Enzymatic Chemical
1.726, 1.768 1.724, 1.782 2.552, 2.614 2.144, 3.038
Control subjects Subjects with IGT
